Uropocit Mist potassium citrate Mopson 180ml

**Composition:**

• **Active Ingredient:** Potassium Citrate
• **Formulation:** Oral solution or mist
• **Concentration:** Typically, each 5 mL of Uropocit Mist contains 1.5 g of Potassium Citrate.
• **Excipients:** May include purified water, citric acid, flavoring agents, and preservatives as needed for stability and palatability.

**Dosage:**

• **Adults:** The usual dosage is 15 mL (equivalent to 4.5 g of Potassium Citrate) taken three times daily, preferably after meals.
• **Children:** Dosage should be determined by a healthcare provider based on the child's weight and clinical condition, typically ranging from 5 mL to 10 mL three times daily.
• **Administration:** The solution can be taken directly or diluted in water or juice for better taste.

**Indications:**

• **Management of Urinary Alkalinization:** Uropocit Mist is indicated for the prevention and management of certain types of kidney stones, particularly uric acid stones and cystine stones, by alkalinizing the urine.
• **Hypokalemia:** It may be used to treat or prevent low potassium levels in the blood, especially in patients who are on diuretics or have conditions leading to potassium loss.
• **Metabolic Acidosis:** Uropocit Mist can be indicated in cases of metabolic acidosis, where there is a need to correct the acid-base balance in the body.

**Contraindications:**

• Hyperkalemia (high potassium levels)
• Severe renal impairment
• Adrenal insufficiency

**Precautions:**

• Monitor potassium levels regularly during treatment.
• Use with caution in patients with renal disease or those on potassium-sparing diuretics.

**Side Effects:**

• Gastrointestinal disturbances (nausea, vomiting, diarrhea)
• Abdominal discomfort
• Rarely, hyperkalemia

**Note:** Always consult a healthcare professional before starting any new medication or treatment regimen. Adjustments to dosage may be necessary based on individual patient needs and response to therapy.